Aspergillus fumigatus colonization in cystic fibrosis: Implications for lung function?

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1381-1386

  de Vrankrijker, A M M ^a   van der Ent, C K ^a   van Berkhout, F T ^a   Stellato, R K ^a   Willems, R J L ^a   Bonten, M J M ^a   Wolfs, T F W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aspergillus fumigatus; Colonization; Cystic fibrosis; Lung disease; Lung function

Indexed keywords

ANTIBIOTIC AGENT; DEOXYRIBONUCLEASE;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HOMOZYGOSITY; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; LUNG ASPERGILLOSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PANCREAS INSUFFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SPUTUM CULTURE; THROAT CULTURE;

ASPERGILLUS FUMIGATUS;

EID: 79957529529     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03429.x     Document Type: Article

References (20)

1. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990; 116: 714-719.
2. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979; 120: 863-873.
3. Bauernfeind A, Bertele RM, Harms K et al. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 1987; 15: 270-277.
4. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994; 105: 32-36.
5. Becker JW, Burke W, McDonald G et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 1996; 109: 1536-1540.
6. Milla CE, Wielinski CL, Regelmann WE. Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients. Pediatr Pulmonol 1996; 21: 6-10.
7. Skov M, Koch C, Reimert CM, Poulsen LK. Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Allergy 2000; 55: 50-58.
8. Bakare N, Rickerts V, Bargon J, Just-Nubling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003; 46: 19-23.
9. Skov M, McKay K, Koch C, Cooper PJ. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Respir Med 2005; 99: 887-893.
10. Valenza G, Tappe D, Turnwald D et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 2008; 7: 123-127.
11. Bargon J, Dauletbaev N, Kohler B et al. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respir Med 1999; 93: 835-838.
12. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006; 174: 1211-1220.
13. Shoseyov D, Brownlee KG, Conway SP, Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest 2006; 130: 222-226.
14. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010; 137: 171-176.
15. TNO Prevention and Health Leiden University Medical Centre. Growth diagrams 1997. Houten, the Netherlands: Bohn Stafleu Van Loghum, 1998.
16. Stevens DA, Moss RB, Kurup VP et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (suppl 3): S225-S264.
17. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118: 201-210.
18. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1-9.
19. Burns JL, Van Dalfsen JM, Shawar RM et al. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 1999; 179: 1190-1196.
20. Pihet M, Carrere J, Cimon B et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review. Med Mycol 2009; 47: 387-397.